SANDY HONG: Open Payments
NPI 1114590478 · LITTLE ELM, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,317 in 68 payments from 14 companies in 2025. Trend: 2023 $423 · 2024 $2,933 · 2025 $1,317
Food & beverage: $1,317
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $260 |
| E.R. Squibb & Sons, L.L.C. | 14 | $237 |
| Supernus Pharmaceuticals, Inc. | 18 | $224 |
| Neurocrine BioSciences, Inc. | 3 | $96 |
| Alkermes, Inc. | 5 | $87 |
| Axsome Therapeutics, Inc. | 3 | $82 |
| Vanda Pharmaceuticals Inc. | 3 | $79 |
| Janssen Pharmaceuticals, Inc | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Lundbeck LLC | 2 | $39 |
Products named: COBENFY, REXULTI, Qelbree, INGREZZA, ARISTADA, Auvelity, FANAPT, CAPLYTA.
Industry payments across TX — which companies pay providers there.
